Xiufeng, Zhu <br/><br/>
Co-operation of ABT-199 and gemcitabine in impeding DNA damage repair and inducing cell apoptosis for synergistic therapy of T-cell acute lymphoblastic leukemia.  [electronic resource] 

 -  Anti-cancer drugs  02 2019 
 - 138-148 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000702  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis<br/>Bridged Bicyclo Compounds, Heterocyclic--administration & dosage<br/>Case-Control Studies<br/>Cell Proliferation<br/>DNA Damage<br/>DNA Repair<br/>Deoxycytidine--administration & dosage<br/>Drug Synergism<br/>Humans<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Sulfonamides--administration & dosage<br/>Tumor Cells, Cultured<br/>Gemcitabine